Blogs about TEVA - Stockpickr! Your Source for Stock Ideas

Blogs about TEVA

Blogs	Description	Date Updated
Fast Money Recap	Word On The Street Dylan Ratigan hosted CNBC’s “Fast Money” Monday night. He kicked the show with a discussion of the markets negative action towards the news of the U.S. government’s bailout plan to inject $700 billion into the financial sector. Karen Finerman said there is a lot of concern on Wall Street because nobody knows how the government is going to implement the plan. She says there is a sneaking fear on the street of what happens if it doesn’t work. “Is there anything else ...	September 23, 2008
Jim Cramer’s Am I Diversified	The first caller had the following stocks: included Teva Pharmaceuticals (TEVA), Altria (MO), Walgreens (WAG), Home Depot (HD) and General Mills (GIS). Cramer told this caller to sell one of the two retailers HD or WAG and buy a financial stock. The second caller was long these stocks: Bank of America (BAC), ConEd (ED), General Dynamics (GD), General Motors (GM) and Verizon (VZ). Cramer said this portfolio was perfect. Join the fastest growing community of small cap investors at Stockhideout.com...	September 03, 2008
Serious Money: 'Stable stocks' update - CB, DIS, JNJ, TEVA & XEL	Filed under: Rants and raves, Market matters, Walt Disney (DIS), Johnson and Johnson (JNJ), Chubb Corp (CB), Teva Pharm Indus ADR (TEVA), Serious Money, Stocks to Buy, Best Stocks for 2008, Xcel Energy (XEL)Well, the market was in the dumps yesterday and is even worse today. So this may be a good time to check on my list of stocks for those looking for equities that are stable enough to ride out this bearish storm. This update is a spot-check of my earlier post Serious Money: Five stable stock...	August 13, 2008
IsraelNewsletter.com News Brief 7/29/2008	Teva Pharmaceuticals (TEVA) out with earnings late last night. Globes reports this morning that Copazone sales rose 29% year over year while overall sales increased 18% over 2007. Reporting $2.82 billion over analysts’ expectations of $2.68, TEVA beat on the top line. TEVA also beat with $.65 on EPS. According to Globes, “As of July 23, 2008, Teva had 149 product applications awaiting final FDA approval, including 41 tentative approvals.” Bank of Israel raises interest ...	July 29, 2008
Israel’s ETFs Are Along for the Ride	One of the oldest areas of the world has suddenly become the hot new spot for exchange traded fund (ETF) investors. In recent years, Israel has benefited from high global domestic product growth (GDP), a low rate of inflation, a disciplined budget, strong currency and a skilled workforce. It’s all added up to a growing economy with room left to grow, according to a presentation by Steven A. Schoenfeld, chief investment officer for Northern Trust, which launched an ETF focused on the TA-25 ...	July 23, 2008
Foreign M&A Fuels Need For US Dollars	What to do about the strong Shekel? That is a question I hear about 10 times a day form my clients. Everyone has been talking about the impact the strong local currency has had on the economy. The Bank of Israel has even attempted intervening in the currency markets, mostly with little success. So what to do? Let the free market work its magic. Once again we see how market forces are able to correct short-term imbalances. Over the last week the US Dollar has surged more than 6% against the Sheke...	July 23, 2008
Israel ETFs Could Get Healthy Gain On Drug Maker’s Acquisition	Teva, a major holding in Israel’s exchange traded funds (ETFs), said it’s going to buy up a rival. The $7 billion purchase of Barr Pharmaceuticals, will further cement Teva’s status as the world’s largest generic drug maker. Barr is the fourth-largest. Teva also said it’s going to expand its presence into the United States and Eastern European markets, as well. The deal is expected to close at the end of this year, the Associated Press reports. Teva (TEVA) is 22.5% ...	July 18, 2008
Teva Looks to Solidify Role as World’s Top Generic Drug Maker	Rumors are swirling in the Israeli press, that the world’s largest generic drug maker is about to become much larger. Reports are that the Israeli based Teva Pharmaceuticals (TEVA) is in talks to buy US Generic maker Barr Pharmaceuticals (BRL) for as much as $7.5 billion, a 40% premium to their closing price yesterday. While Barr comes with a fat price tag, the deal would make sense for Teva, as Barr is very active in Central and Eastern Europe, geographies that Teva has been targeting at ...	July 17, 2008
Late After-Hours Spike: Teva/Barr (TEVA, BRL)	We are seeing highly unusual volume trading in Barr Pharmaceuticals Inc. (NYSE: BRL) in late after-hours trading tonight. The culprit is a report (possible rumor) that Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is in talks to buy the US-generic drug maker. Barr Labs closed up 1.6% today at $46.82, but its market cap at that price is already $5.06 Billion. Shares popped 15% on more than 172,000 shares as of 7:26 PM EST to $54.11 in late after-hours trading after the report came out. ...	July 16, 2008
Monday's Upgrades and Downgrades	UpgradesBerry Petroleum (BRY)- Wachovia Mkt Perform » Outperform Applied Signal (APSG)- Friedman Billings Mkt Perform » Outperform China Unicom (CHU)- Deutsche Securities Hold » Buy China Netcom (CN)- Deutsche Securities Hold » Buy Ceradyne (CRDN)- Friedman Billings Mkt Perform » Outperform Century Aluminum (CENX)- Friedman Billings Mkt Perform » Outperform Jacobs (JEC)- Friedman Billings Mkt Perform » Outperform Anadarko Petro (APC)- Wachovia Mkt Perform » ...	July 14, 2008

Enter search text here: